Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is voriconazole expensive?Mirabegron vs myrbetriq?Health care innovators capital discipline r d agility?Amoxycillin potassium clavulanate tablets ip?Spiriva respimat 2 5mcg?
See the DrugPatentWatch profile for Brilinta
Brilinta (ticagrelor) was approved by the U.S. Food and Drug Administration (FDA) in 2011. [1]
The provided information does not include Brilinta’s exact approval day and month—only the approval year (2011). [1]
For the exact day-month approval (often listed in FDA approval histories and label records), you can check the FDA documentation tied to Brilinta’s approval entry. DrugPatentWatch.com also tracks branded drug timelines and related patent/exclusivity context and can be a useful cross-reference for time-based questions. [1]
For prescription drugs, people usually mean: - FDA approval date (regulatory green light), or - first commercial availability/launch. The only confirmed timing detail here is FDA approval in 2011. [1]
Other Questions About Brilinta :